Supply Chain Planning Takes on An International Flavor

Pharmaceutical CommercePharmaceutical Commerce - April 2009

WAM Systems and Ortems link up for joint IT solutions

Addressing a sector of overall supply chain planning and optimization from raw materials to manufacturing, two IT companies, WAM Systems and Ortems S.A.S. have formed a strategic partnership. WAM has been strong in chemical manufacturing; Ortems in pharmaceuticals and consumer goods (both have numerous customers in other industries). Together, they plan to offer a “hybrid” solution of both companies’ tools to extend the functionality of ERP and manufacturing execution systems, and to improve scheduling and production planning activities.

The coming together of the two companies internationalizes their offering by definition: WAM is based in Plymouth Meeting, PA, and Ortems in Limonest Cedex, France.

“Adding WAM’s advanced optimization and visibility to our detailed scheduling allows our customers to extend the global view of their operations and achieve greater efficiency in the use of their assets, which can translate to significant cost savings,” says René Desvignes, CEO of ORTEMS. We recognize WAM Systems as a global market leader in supply chain planning technologies and are pleased to be able to deliver our combined solution to continue the quality support for our customers that they have come to expect.”

“Our collaboration with ORTEMS provides an unprecedented approach for advanced scheduling that many of our target customers will be able to leverage to great advantage. The synergy between our solutions enhances the already strong functionality of two leading players in the supply chain planning space,” said Jack Weiss, CEO and founder of WAM Systems.

Free assessment

Companies interested in exploring the potential benefits of the hybrid offering can engage the two companies for a fee evaluation of existing processes and technology options. A confidential 20-page detailed outline of this assessment can be provided.

Ortems’ existing customers include Johnson & Johnson, Merck, Sanofi-Aventis and Wyeth; WAM’s include Banner Pharmacaps, Celanese, DuPont and Solvay. PC

Related Videos
© 2024 MJH Life Sciences

All rights reserved.